health - "develop"

HONG KONG (Reuters) - Breathing second-hand tobacco smoke significantly increases the risk of women developing peripheral artery disease (PAD), heart disease and stroke, a study in China has found.Previous studies have drawn strong links between passive smoking and stroke and heart disease, but this is the first time that an association between second-hand smoke and PAD has been found.PAD is a circulatory problem in which narrowed arteries reduce blood flow to the limbs, causing pain and increasing the risk of suffering a heart attack or stroke.

A new study links exposure to secondhand tobacco smoke to an increased risk of developing peripheral artery disease (PAD), heart disease and stroke among women.

AVEO Pharmaceuticals, Inc., announced that it has initiated a Phase 1 clinical trial to evaluate the safety, tolerability and recommended dose of SCH900105 (AV-299), its novel, highly potent antibody to hepatocyte growth factor (HGF), administered intravenously in patients with relapsed or refractory solid tumors or lymphoma. SCH900105 (AV-299) is being developed in collaboration with Schering-Plough (NYSE: SGP).

People with a family history of cancerous brain tumors appear to be at higher risk of developing the same kind of tumors compared to people with no such family history, according to a study published in the September 23, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers looked at the medical records of 1,401 people from Utah with primary brain tumors.

HealthDay - TUESDAY, Sept. 23 (HealthDay News) -- Nasally administeredinsulin won't protect children at high risk of developing type 1 diabetesfrom getting the illness, Finnish researchers say.

A new analysis indicates an association between a gene involved in vitamin D metabolism and skin cancer. Published in the November 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of developing melanoma.

Cancer patients with tumors that have spread to the brain (brain metastases) who undergo stereotactic radiosurgery (SRS) and whole brain radiation have more than double the risk of developing learning and memory problems, compared to those who only have stereotactic radiosurgery, according to a randomized study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.

Young adults and men do not see themselves as susceptible to osteoporosis, according to a new study. In their minds, the risk of suffering from what many consider an older woman's disease seems distant or slim. The problem: They are missing preventive measures that if taken now, could decrease their future danger of developing the disease.read more

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) announced today that it has enrolled the first subject in its Phase IB clinical trial in which RGN-352 is being tested in 40 healthy subjects. RGN-352 is an injectable formulation of Tβ4 being developed to reduce cardiac damage in patients after an acute myocardial infarction (AMI or heart attack), as well as for other potential systemic uses.

HealthLinx Limited and Canadian-based InSymbiosis Discovery (InSymbiosis) have signed a letter of intent to co-develop HTX's peptide therapeutic CR014 and related compounds for applications in Acute Respiratory Distress Syndrome (ARDS) and Acute Lung Injury. The companies will proceed under a joint venture agreement, subject to the completion of due diligence. ARDS is a complex syndrome that affects the vital functions of the lungs. At present, there are no effective therapeutic treatments available and 30-40% of patients who develop the syndrome will die. CR014 has demonstrated efficacy i...